Is NEO Worth Buying in 2026?

NeoGenomics, Inc.

STOCK SERVICES-TESTING LABORATORIES Updated 2026-05-03

Here’s whether NeoGenomics, Inc. (NEO) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +30.0%; rising volume confirms the move (1.31x 30d avg). Concerns: 50-day MA is falling (-5.64% over 10 days); 3-month momentum negative (-23.3%). Currently 31.3% off its 52-week high. Score: +3/7.

Ready to act on this? 📈 Trade on Webull

NEO is in a confirmed uptrend, trading above both its 50-day ($8.49) and 200-day ($9.42) moving averages. An RSI of 68.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +30.0% compares to +24.4% for SPY (beat the market by 5.7%). The current 31.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $13,003 today
vs. S&P 500 (SPY) — same period beat market by 5.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($9.42)
Above 50-day MA ($8.49)
RSI(14) neutral zone (30–70) — currently 68.4
Positive return (+30.0%)
!Within 10% of period high (−31.3%)
Period Range $9.44
$4.72 $13.74
RSI (14) 68.4
0 · OversoldOverbought · 100

Key Metrics

Price$9.44
Period Return+30.0%
Period High$13.74
Period Low$4.72
Drawdown−31.3%
MA-50$8.49
MA-200$9.42
RSI (14)68.4
Avg Volume (30d)2.4M
vs. SPYbeat by 1.0%
Return Rank#474 of 1245

Trade NEO

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers